Internal Medicine, Infectious Disease · Las Vegas, NV
NPI
1841288107
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1771 E Flamingo Rd Ste 216
Las Vegas, NV, 89119
Phone (702) 991-2999
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
931 services
Medicare patients, 2024
71
Average age 72
Drug cost, 2024
$529K
733 prescriptions
Company payments, 2025
$271
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cara Fanning was code 99232 (hospital e&m - subsequent), 497 times for 50 patients. In total Cara Fanning billed 931 services in 6 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 497 | 50 | $60.18 | $30K |
| 99233 Hospital E&M - Subsequent | Facility | 342 | 61 | $90.63 | $31K |
| 99223 Hospital E&M - Initial | Facility | 64 | 48 | $132.44 | $8,476 |
| 99214 Office E&M - Established | Office | 24 | 11 | $86.33 | $2,072 |
By year: 2022 $102K for 1,425 services; 2023 $83K for 1,034 services; 2024 $72K for 931 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cara Fanning prescribed most often to Medicare patients was Daptomycin, with 177 prescriptions and refills. In total Cara Fanning wrote 733 Medicare prescriptions that cost $529K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 177 | 177 | 36 | $272K |
| Meropenem Generic | 101 | 101 | 20 | $45K |
| Ertapenem Ertapenem Sodium | 86 | 86 | 18 | $43K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 43 | 43 | Under 11 | $9,132 |
| Imipenem-Cilastatin Sodium Imipenem/Cilastatin Sodium | 38 | 38 | Under 11 | $17K |
| Amikacin Sulfate Generic | 33 | 33 | Under 11 | $2,128 |
| Cefepime Hcl Generic | 31 | 31 | Under 11 | $8,529 |
| Ceftriaxone Ceftriaxone Sodium | 28 | 28 | Under 11 | $1,229 |
| Micafungin Micafungin Sodium | 22 | 22 | Under 11 | $5,734 |
| Cefazolin Sodium Generic | 21 | 21 | Under 11 | $1,197 |
| Dovato Dolutegravir Sodium/Lamivudine | 18 | 18 | Under 11 | $61K |
| Fluconazole Generic | 15 | 15 | Under 11 | $503 |
| Teflaro Ceftaroline Fosamil Acetate | 11 | 11 | Under 11 | $18K |
| Ciprofloxacin Hcl Generic | 11 | 11 | Under 11 | $176 |
| Doxycycline Hyclate Generic | 11 | 11 | Under 11 | $140 |
Brand drugs: 47 claims; generic drugs: 686 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cara Fanning $271 ($271 in general payments such as food, travel and fees) from 4 companies. The largest payer was Merck Sharp & Dohme LLC with $182.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.